Benzinga | Mar 26, 2021 09:00AM EDT

AstraZeneca Shares Quiet Following European Medicines Agency Comment A New Manufacturing Site Has Been Approved For Production Of Co.'s COVID-19 Vaccine Active Substance

-Reuters